INSIGHTS ON DRUG DEVELOPMENT

• Direct qPCR Amplification From Human Urine Samples

  Extraction-free qPCR enables faster, lower-cost detection of UTI-associated bacteria directly from urine samples. Explore how this approach simplifies workflows and accelerates time to results.

• A Sensory Panel Study With The Focus On High-Intensity Sweeteners

  Gain insight into the sensory performance of five high-intensity sweeteners in a simulated bitter formulation, including their effects on sweetness, bitterness, aftertaste, and covering ability.

• Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery

  Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.

• Maintain Control Of Pharmaceutical Water Systems

  Early TOC excursions often reveal hidden risks in water systems. Capturing samples at the moment of deviation helps teams confirm root causes faster, reduce uncertainty, and maintain control.

• Cell Retention Technology And Specialized Cell Culture Media

  8/11/2025

  Explore how perfusion technology is transforming upstream bioprocessing by boosting productivity, reducing costs, and enabling process intensification while overcoming cell retention challenges.

• Rheological Properties Of Pharmaceutical Excipients: Lactose Monohydrate And Carboxymethyl Cellulose

  12/30/2024

  Explore lactose monohydrate and CMC rheology, highlighting their flow, cohesion, and compressibility properties to optimize pharmaceutical formulations under varying stress and temperature conditions.

• The Role Of CDMOs In Supporting Generic Drug Development

  7/15/2025

  Bringing complex generics to market requires deep expertise. Learn how a CDMO can help navigate regulatory, technical, and commercial challenges with end-to-end development and manufacturing support.

• Unleash The Potential For Polyvinyl Alcohol In Spray Drying

  6/4/2025

  Discover how polyvinyl alcohol (PVA) addresses key formulation challenges in oral solid dosage forms to enhance solubility and stability across diverse APIs, which include emerging drug classes like PROTACs.

• Fast And Accurate Detection Of Alzheimer's Disease Targets

  9/17/2024

  In this study, the detection of three Alzheimer’s disease targets are highlighted: Human BDNF (Brain-derived neurotrophic factor), Tau, and TREM2 (Triggering receptor expressed on myeloid cells 2).